CUI1 stringlengths 8 8 | RELA stringlengths 3 54 | CUI2 stringlengths 8 8 | Name1 stringlengths 1 2.86k ⌀ | Name2 stringlengths 1 2.86k ⌀ | Def1 stringlengths 1 8.95k ⌀ | Def2 stringlengths 1 8.95k ⌀ |
|---|---|---|---|---|---|---|
C0000598 | has_salt_form | C0040207 | ticlopidine hydrochloride | ticlopidine | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. |
C0000598 | subset_includes_concept | C1880653 | ticlopidine hydrochloride | FDA Established Names and Unique Ingredient Identifier Codes Terminology | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices. |
C0000598 | has_ingredient | C0710150 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet [Ticlid] | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_active_ingredient | C0980728 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | inverse_isa | C0040207 | ticlopidine hydrochloride | ticlopidine | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. |
C0000598 | isa | C0980728 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | inverse_isa | C0040207 | ticlopidine hydrochloride | ticlopidine | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. |
C0000598 | parent_of | C2267102 | ticlopidine hydrochloride | T [Preparations] | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_form | C0040207 | ticlopidine hydrochloride | ticlopidine | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. |
C0000598 | has_precise_ingredient | C0733418 | ticlopidine hydrochloride | Ticlid | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_contraindicated_drug | C0005779 | ticlopidine hydrochloride | Blood Coagulation Disorders | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. |
C0000598 | may_be_treated_by | C0007781 | ticlopidine hydrochloride | Intracranial Embolism and Thrombosis | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures. |
C0000598 | has_contraindicated_drug | C0013182 | ticlopidine hydrochloride | Drug Allergy | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Immunologically mediated adverse reactions to medicinal substances used legally or illegally. |
C0000598 | has_contraindicated_drug | C0019080 | ticlopidine hydrochloride | Hemorrhage | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Bleeding or escape of blood from a vessel. |
C0000598 | may_be_prevented_by | C0022116 | ticlopidine hydrochloride | Ischemia | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. |
C0000598 | has_contraindicated_drug | C0023895 | ticlopidine hydrochloride | Liver diseases | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Pathological processes of the LIVER. |
C0000598 | may_be_prevented_by | C0038454 | ticlopidine hydrochloride | Cerebrovascular accident | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic ... |
C0000598 | may_be_prevented_by | C0040038 | ticlopidine hydrochloride | Thromboembolism | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. |
C0000598 | may_be_prevented_by | C0042487 | ticlopidine hydrochloride | Venous Thrombosis | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | The formation or presence of a blood clot (THROMBUS) within a vein. |
C0000598 | physiologic_effect_of | C0855739 | ticlopidine hydrochloride | Decreased Platelet Aggregation [PE] | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_precise_ingredient | C1123715 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | mechanism_of_action_of | C1373126 | ticlopidine hydrochloride | Platelet Activating Factor Inhibitors | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_boss | C4719908 | ticlopidine hydrochloride | ticlopidine hydrochloride Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | therapeutic_class_of | C4722027 | ticlopidine hydrochloride | Blood Products/Modifiers/Volume Expanders [TC] | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | inverse_isa | C0032177 | ticlopidine hydrochloride | Platelet Aggregation Inhibitors | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. |
C0000598 | inverse_isa | C0085826 | ticlopidine hydrochloride | Antiplatelet Agents | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | An agent that inhibits platelet aggregation and reduces coagulation in the circulatory system. |
C0000598 | inverse_isa | C0244167 | ticlopidine hydrochloride | chlorobenzene | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | benzene derivatives with chlorine substituted at one or more positions. |
C0000598 | inverse_isa | C1320237 | ticlopidine hydrochloride | Drug allergens | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | inverse_isa | C5551427 | ticlopidine hydrochloride | P2Y12 G-protein-coupled platelet receptor antagonist | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_modification | C0040207 | ticlopidine hydrochloride | ticlopidine | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. |
C0000598 | has_active_ingredient | C0980728 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_basis_of_strength_substance | C0980728 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_precise_active_ingredient | C0980728 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | disposition_of | C4722254 | ticlopidine hydrochloride | Platelet aggregation inhibitor (disposition) | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | disposition_of | C5551429 | ticlopidine hydrochloride | P2Y12 G-protein-coupled platelet receptor antagonist (disposition) | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000598 | has_ingredient | C0980728 | ticlopidine hydrochloride | ticlopidine hydrochloride 250 MG Oral Tablet | The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits adenosine-diphosphate (ADP)-induced platelet-fibrinogen binding by binding to the glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.... | null |
C0000608 | has_ingredient | C0687856 | 6-aminocaproic acid | 6-aminocaproic acid 500 MG Oral Tablet | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_ingredient | C0775169 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Injectable Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_ingredient | C1509250 | 6-aminocaproic acid | 6-aminocaproic acid 1000 MG Oral Tablet | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_ingredient | C1614061 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Oral Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_ingredient | C1657165 | 6-aminocaproic acid | Aminocaproic Acid Bulk powder | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_ingredient | C4048642 | 6-aminocaproic acid | 20 ML 6-aminocaproic acid 250 MG/ML Injection | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_ingredient | C4082878 | 6-aminocaproic acid | aminocaproic acid 250 MG/ML includes Injection and Injectable Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | associated_with | C0524007 | 6-aminocaproic acid | Aminocaproate trough measurement | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | tradename_of | C0702045 | 6-aminocaproic acid | Amicar | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | inverse_isa | C0019120 | 6-aminocaproic acid | Hemostatic Agents | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming... |
C0000608 | subset_includes_concept | C1880653 | 6-aminocaproic acid | FDA Established Names and Unique Ingredient Identifier Codes Terminology | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices. |
C0000608 | subset_includes_concept | C5447243 | 6-aminocaproic acid | NCI Drug Dictionary Terminology | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | Terminology created to support the National Cancer Institute (NCI) Drug Dictionary. |
C0000608 | subset_includes_concept | C5910040 | 6-aminocaproic acid | HemOnc Agent Terminology | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | A terminology set that includes pharmacologic agents found in the HemOnc knowledge base. |
C0000608 | has_active_ingredient | C0687856 | 6-aminocaproic acid | 6-aminocaproic acid 500 MG Oral Tablet | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C0687856 | 6-aminocaproic acid | 6-aminocaproic acid 500 MG Oral Tablet | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C1509250 | 6-aminocaproic acid | 6-aminocaproic acid 1000 MG Oral Tablet | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C1509250 | 6-aminocaproic acid | 6-aminocaproic acid 1000 MG Oral Tablet | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C4081234 | 6-aminocaproic acid | sodium monofluorophosphate 0.0074 MG/MG Toothpaste | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5221372 | 6-aminocaproic acid | SILICON DIOXIDE 18.0 g in 120 g / ALCLOXA 0.15 g in 120 g / Aminocaproic Acid 0.20 g in 120 g TOPICAL PASTE, DENTIFRICE [LACSIAN new perfect all care tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5563958 | 6-aminocaproic acid | CALCIUM CARBONATE 10.30 g in 100 g / ALCLOXA 0.05 g in 100 g / Aminocaproic Acid 0.05 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.30 g in 100 g ORAL GEL, DENTIFRICE [ROOTSALLO TOOTHPASTE] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5578614 | 6-aminocaproic acid | Silicon Dioxide 17.0 g in 100 g / Aminocaproic Acid 0.1 g in 100 g / ALCLOXA 0.1 g in 100 g ORAL PASTE, DENTIFRICE [Dr.LORD Green Propol Tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C0713516 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Oral Solution [Amicar] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C0713516 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Oral Solution [Amicar] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C0713523 | 6-aminocaproic acid | 6-aminocaproic acid 500 MG Oral Tablet [Amicar] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C0713523 | 6-aminocaproic acid | 6-aminocaproic acid 500 MG Oral Tablet [Amicar] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C0775169 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Injectable Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C0775169 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Injectable Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C1585092 | 6-aminocaproic acid | 6-aminocaproic acid 1000 MG Oral Tablet [Amicar] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C1585092 | 6-aminocaproic acid | 6-aminocaproic acid 1000 MG Oral Tablet [Amicar] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C1590066 | 6-aminocaproic acid | sodium monofluorophosphate 0.0076 MG/MG Toothpaste | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C1614061 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Oral Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C1614061 | 6-aminocaproic acid | 6-aminocaproic acid 250 MG/ML Oral Solution | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C2954738 | 6-aminocaproic acid | SILICON DIOXIDE 20 g in 100 g / SODIUM FLUORIDE 0.22 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g / GLYCYRRHIZINATE DIPOTASSIUM 0.04 g in 100 g / URSODIOL 0.02 g in 100 g / Curcuma xanthorrhiza oil 0.025 g in 100 g / SEA SALT 3 g in 100 g DENTAL PASTE [BAMBOO SALT Eunganggo Jook Yeom Toothpaste] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C2954738 | 6-aminocaproic acid | SILICON DIOXIDE 20 g in 100 g / SODIUM FLUORIDE 0.22 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g / GLYCYRRHIZINATE DIPOTASSIUM 0.04 g in 100 g / URSODIOL 0.02 g in 100 g / Curcuma xanthorrhiza oil 0.025 g in 100 g / SEA SALT 3 g in 100 g DENTAL PASTE [BAMBOO SALT Eunganggo Jook Yeom Toothpaste] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C2955550 | 6-aminocaproic acid | CALCIUM CARBONATE 15.85 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.6 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g / ALCLOXA 0.05 g in 100 g DENTAL PASTE, DENTIFRICE [Solmeet denti doctor] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C2955550 | 6-aminocaproic acid | CALCIUM CARBONATE 15.85 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.6 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g / ALCLOXA 0.05 g in 100 g DENTAL PASTE, DENTIFRICE [Solmeet denti doctor] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C2979126 | 6-aminocaproic acid | CALCIUM CARBONATE 31.25 g in 100 g DENTAL PASTE, DENTIFRICE [Insan Bamboosalt toothpaste] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C3883041 | 6-aminocaproic acid | ALLANTOIN 0.12 mg in 600 mL / GLYCERIN 6 mg in 600 mL TOPICAL GEL [Seniorclean Bio] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C4019915 | 6-aminocaproic acid | MENTHOL 0.63 g in 632.19 g TOPICAL GEL [ODEUR Senior Premium Cleanser] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C4048642 | 6-aminocaproic acid | 20 ML 6-aminocaproic acid 250 MG/ML Injection | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C4048642 | 6-aminocaproic acid | 20 ML 6-aminocaproic acid 250 MG/ML Injection | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C4275653 | 6-aminocaproic acid | GLYCERIN 7.68 g in 120 g DENTAL PASTE, DENTIFRICE [Dr Deep Deep Fresh] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C4293977 | 6-aminocaproic acid | sodium monofluorophosphate 0.004 MG/MG Toothpaste | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_inactive_ingredient | C4301850 | 6-aminocaproic acid | SILICON DIOXIDE 170 mg in 1 g ORAL PASTE [Olea Olidental] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C4535010 | 6-aminocaproic acid | XYLITOL 0.1 g in 100 g / GREEN TEA LEAF 0.1 g in 100 g / ASCORBIC ACID 0.005 g in 100 g / LEVOMENTHOL 0.1 g in 100 g / PEPPERMINT OIL 0.05 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g / WATER 45.15 g in 100 g TOPICAL PASTE, DENTIFRICE [YUMAKI ORIGINAL MINT TOOTH] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C4535010 | 6-aminocaproic acid | XYLITOL 0.1 g in 100 g / GREEN TEA LEAF 0.1 g in 100 g / ASCORBIC ACID 0.005 g in 100 g / LEVOMENTHOL 0.1 g in 100 g / PEPPERMINT OIL 0.05 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g / WATER 45.15 g in 100 g TOPICAL PASTE, DENTIFRICE [YUMAKI ORIGINAL MINT TOOTH] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C4694894 | 6-aminocaproic acid | AMINOCAPROIC ACID 0.02 g in 100 g ORAL PASTE [Solco Platino Iondenti Tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C4694894 | 6-aminocaproic acid | AMINOCAPROIC ACID 0.02 g in 100 g ORAL PASTE [Solco Platino Iondenti Tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C4704472 | 6-aminocaproic acid | CALCIUM CARBONATE 36.0 g in 120 g / ANHYDROUS DIBASIC CALCIUM PHOSPHATE 0.12 g in 120 g / ALCLOXA 0.12 g in 120 g / AMINOCAPROIC ACID 0.12 g in 120 g ORAL PASTE, DENTIFRICE [28TAK GUM CARE TOOTH] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C4704472 | 6-aminocaproic acid | CALCIUM CARBONATE 36.0 g in 120 g / ANHYDROUS DIBASIC CALCIUM PHOSPHATE 0.12 g in 120 g / ALCLOXA 0.12 g in 120 g / AMINOCAPROIC ACID 0.12 g in 120 g ORAL PASTE, DENTIFRICE [28TAK GUM CARE TOOTH] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5209708 | 6-aminocaproic acid | AMINOCAPROIC ACID 0.1 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.5 g in 100 g / CALCIUM CARBONATE 7.42 g in 100 g / ALCLOXA 0.06 g in 100 g ORAL PASTE [HiMangChanToothpaste] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5209708 | 6-aminocaproic acid | AMINOCAPROIC ACID 0.1 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.5 g in 100 g / CALCIUM CARBONATE 7.42 g in 100 g / ALCLOXA 0.06 g in 100 g ORAL PASTE [HiMangChanToothpaste] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5210633 | 6-aminocaproic acid | AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5210633 | 6-aminocaproic acid | AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5221372 | 6-aminocaproic acid | SILICON DIOXIDE 18.0 g in 120 g / ALCLOXA 0.15 g in 120 g / Aminocaproic Acid 0.20 g in 120 g TOPICAL PASTE, DENTIFRICE [LACSIAN new perfect all care tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5221534 | 6-aminocaproic acid | AMINOCAPROIC ACID 1 kg in 1 kg NOT APPLICABLE POWDER | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5221534 | 6-aminocaproic acid | AMINOCAPROIC ACID 1 kg in 1 kg NOT APPLICABLE POWDER | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5383620 | 6-aminocaproic acid | AMINOCAPROIC ACID 0.09 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.09 g in 100 g / CALCIUM CARBONATE 37 g in 100 g / ALCLOXA 0.09 g in 100 g ORAL PASTE [Hae Yan Tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5383620 | 6-aminocaproic acid | AMINOCAPROIC ACID 0.09 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.09 g in 100 g / CALCIUM CARBONATE 37 g in 100 g / ALCLOXA 0.09 g in 100 g ORAL PASTE [Hae Yan Tooth] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5398657 | 6-aminocaproic acid | SILICON DIOXIDE 16 g in 100 g / AMINOCAPROIC ACID 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [mastikis gold] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5398657 | 6-aminocaproic acid | SILICON DIOXIDE 16 g in 100 g / AMINOCAPROIC ACID 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [mastikis gold] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5398919 | 6-aminocaproic acid | SILICON DIOXIDE 16 g in 100 g / AMINOCAPROIC ACID 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Mastikis Mastic 24K] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_moiety | C5398919 | 6-aminocaproic acid | SILICON DIOXIDE 16 g in 100 g / AMINOCAPROIC ACID 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Mastikis Mastic 24K] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
C0000608 | has_active_ingredient | C5432990 | 6-aminocaproic acid | CALCIUM CARBONATE 36 g in 100 g / ALCLOXA 0.06 g in 100 g / AMINOCAPROIC ACID 0.06 g in 100 g / CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 0.07 g in 100 g DENTAL PASTE, DENTIFRICE [CLEAN BREATH TOOTH] | An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.